SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...

The first patient has been dosed in the TROPION-Lung17 phase 3 trial evaluating DATROWAY® (datopotamab deruxtecan) compared ...

Hockey fans are invited to join the NHL at the Honda NHL PreGame, the official tailgate party of the 2025 Navy Federal Credit Union NHL Stadium Series!

Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M ...

Anthropic and OpenAI are introducing AI tools for healthcare, raising questions about privacy and data protection amidst increasing regulatory scrutiny.

Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...

Striveworks, a leading developer of cutting-edge artificial intelligence solutions, has been selected to provide AI test and evaluation services for the U.S. Army under a Phase II Small Business ...

Anthropic has unveiled new tools that enable both users and service providers to handle medical data, echoing steps already taken by OpenAI.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued stocks in the Biotechnology industry for Tuesday, January 13, 2026. Let’s ...

France has lifted restrictions on Bangladesh and decided to consider it a “Green” listed country with regards to Covid-19.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...